Lisdexamfetamine Dimesylate Capsule
Solco Healthcare US, LLC · Limited Availability · Reason: Shortage of an active ingredient
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 07/14/2023
- Package NDC
- 43547-604-10
- Generic name
- Lisdexamfetamine Dimesylate Capsule
- Contact info
- 866-931-9829
- Availability
- Limited Availability
- Related info
- On allocation
- Update date
- 06/29/2026
- Dosage form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 43547-604-10)
- Company name
- Solco Healthcare US, LLC
- Shortage reason
- Shortage of an active ingredient
- Status
- Current
- Therapeutic category
- Psychiatry
- Harmonized identifiers (openFDA)
- Application number
- ANDA216266
- Brand name
- LISDEXAMFETAMINE DIMESYLATE
- Generic name
- LISDEXAMFETAMINE DIMESYLATE CAPSULES
- Manufacturer name
- Solco Healthcare US,LLC
- Product NDC
- 43547-604, 43547-602, 43547-603, 43547-605, 43547-606, 43547-607, 43547-608
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- LISDEXAMFETAMINE DIMESYLATE
- RxCUI
- 854830, 854834, 854838, 854842, 854846, 854850, 1593856
- SPL ID
- d6435613-e052-4b4f-8bf7-4acb7458d8df
- SPL set ID
- 68b10d9f-ca3e-493d-a309-45f1d7e08061
- Package NDC
- 43547-602-10, 43547-603-10, 43547-604-10, 43547-605-10, 43547-606-10, 43547-607-10, 43547-608-10
- UNII
- SJT761GEGS
